試す - 無料

"The Vietnam Institute is set to play a key role in fostering regional collaborations as a hub for knowledge exchange & partnerships"

BioSpectrum Asia

|

BioSpectrum Asia Nov 2024

The University of Sydney Vietnam Institute, officially launched in June 2024, aims to enhance Vietnam’s scientific capacity and contribute to the country’s economic and social development.

- Ayesha Siddiqui

"The Vietnam Institute is set to play a key role in fostering regional collaborations as a hub for knowledge exchange & partnerships"

The Institute will foster multidisciplinary research across fields such as health, agriculture, arts, social sciences, business, and Net Zero initiatives. Australian researchers will collaborate closely with Vietnamese counterparts on vital projects, including advancing public health efforts, combating tuberculosis, developing technologies for breast cancer diagnosis, and exploring Vietnam’s potential as a media innovation hub. In an exclusive interview, Institute Director Professor Thu-Anh Nguyen, a renowned infectious diseases and public health researcher, shares insights into how the Vietnam Institute will elevate the country’s research landscape and drive impactful collaborations. Edited excerpts:

What was the rationale behind choosing Vietnam as the location for this institute, and how does the country’s academic and research landscape complement the University of Sydney’s goals?

Vietnam was chosen as the location for the Sydney Vietnam Institute (SVI) because of the strong, long-standing relationship between the University of Sydney and Vietnam. Since the 1990s, over 240 University of Sydney academics have visited Vietnam to work on important shared issues like climate change, health, food security, agricultural technology transformation, ageing populations, urban development and regional economic growth. This history of collaboration made Vietnam an ideal place to deepen academic ties. The SVI’s multidisciplinary research focuses on improving the well-being of communities in Vietnam and beyond through multidisciplinary collaboration. By fostering partnerships between Australian and Vietnamese researchers, the Institute promotes sustainable and mutually beneficial cooperation across all levels of higher education and research engagement.

BioSpectrum Asia からのその他のストーリー

BioSpectrum Asia

BioSpectrum Asia

Waters launches charge detection mass spectrometry technology

US-based Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterisation for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Chulalongkorn University launches Thailand's first master's programme in Nurse Anesthesia

The Faculty of Nursing, Chulalongkorn University, has officially launched the \"Master of Nursing Science Programme in Nurse Anesthesia\" - the first of its kind in Thailand.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

WHO strengthens coordination for NTD programmes and supply chain delivery

The World Health Organization (WHO), together with health ministries, pharmaceutical donours, implementing partners and technical support platforms, is strengthening coordination for neglected tropical disease (NTD) programmes and supply chain delivery, through three major back-to-back meetings in Geneva.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

All-in-one coronavirus vaccines to save millions in future pandemics

A new study reveals that vaccines designed to protect against a wide range of coronaviruses could dramatically reduce deaths and economic disruption and limit the need for lockdowns in the event of another global coronavirus pandemic.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

NTU in Singapore introduces Master of Science course in Chinese Medicine

From 2026, Nanyang Technological University (NTU) in Singapore will start offering a Master of Science in Chinese Medicine to develop highly skilled postgraduates with advanced expertise in both the theoretical foundations and practical applications of Chinese medicine.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

ProSpecBio launches Activin-A recombinant protein for brain injury research

Israel-based ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, has announced the launch of its latest product: CHO cell-derived recombinant Activin-A, now available for immediate delivery worldwide.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

PAHO publishes guide for designing AI instructions in public health

The Pan American Health Organization (PAHO) has launched a new guide providing practical advice on how to create Artificial Intelligence (AI) prompts that generate reliable, relevant, and culturally appropriate content across diverse contexts.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Prerna launches India's first MicroRNA based blood test for breast cancer screening

Precision RNA Biotech (Prerna), a healthcare startup from Hyderabad, India has announced the launch of Cantel, India's first microRNA-based blood test for breast cancer screening.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr

India-based medtech firm Poly Medicure has announced signing of a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, at an Enterprise Value of Rs 324 crore (EUR 31 million).

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in Japan

Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy Subcutaneous Injection, a once-weekly subcutaneous injection formulation of GLP-1 receptor agonist indicated for the treatment of obesity disease.

time to read

1 min

BioSpectrum Asia Nov 2025

Listen

Translate

Share

-
+

Change font size